![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » FDA Grants Emergency Use Authorization for bioMérieux’s COVID-19 Test
FDA Grants Emergency Use Authorization for bioMérieux’s COVID-19 Test
![COVID-19 SWAB testing](https://www.fdanews.com/ext/resources/test/Drug-Images4/COVID-19-swab.gif?t=1585177203&width=430)
BioMérieux has received an emergency use authorization from the FDA for its Biofire COVID-19 diagnostic for use in certain clinical laboratories.
The EUA allows the French devicemaker’s test to be used for detecting SARS-CoV-2 in moderate and high complexity laboratories.
The test detects the virus in approximately 45 minutes using a nasopharyngeal swab. It is run on the company’s automated Filmarray 2.0 and Filmarray Torch systems.
Upcoming Events
-
21Oct